Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

West Pharmaceutical Services Inc. buy Bank of America Co.

Start price
€336.30
16.06.23 / 50%
Target price
€369.72
16.06.24
Performance (%)
-6.69%
End price
€313.80
17.06.24
Summary
This prediction ended on 17.06.24 with a price of €313.80. With a performance of -6.69%, the BUY prediction for West Pharmaceutical Services Inc. by Bank_of_America_Co_ closed slightly in the red. Dividends of €0.73 are taken into consideration when calculating the performance. Bank_of_America_Co_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
West Pharmaceutical Services Inc. -12.237% -12.237% -23.246%
iShares Core DAX® 1.280% 1.320% 13.605%
iShares Nasdaq 100 -2.457% -5.192% 25.941%
iShares Nikkei 225® -2.006% -1.389% 8.973%
iShares S&P 500 -0.662% -1.884% 23.684%

Comments by Bank_of_America_Co_ for this prediction

In the thread West Pharmaceutical Services Inc. diskutieren
Prediction Buy
Perf. (%) -6.69%
Target price 369.725
Change
Ends at 16.06.24

West Pharmaceutical Services, Inc. (NYSE: WST) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating. They now have a $405.00 price target on the stock, up previously from $390.00.
Ratings data for WST provided by MarketBeat

In the thread Trading West Pharmaceutical Services Inc.
Prediction Buy
Perf. (%) -6.69%
Target price 369.725
Change
Ends at 16.06.24

Die von Bank_of_America_Co_ gewählte maximale Laufzeit wurde überschritten